VRDN icon

Viridian Therapeutics

170 hedge funds and large institutions have $1.32B invested in Viridian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 64 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

3% less funds holding

Funds holding: 176170 (-6)

21% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 28

70% less call options, than puts

Call options by funds: $1.81M | Put options by funds: $5.96M

Holders
170
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.81M
Puts
$5.96M
Net Calls
Net Calls Change

Top Buyers

1 +$24.4M
2 +$17.8M
3 +$16.9M
4
PBA
Paradigm Biocapital Advisors
New York
+$9.04M
5
Citadel Advisors
Citadel Advisors
Florida
+$7.84M

Top Sellers

1 -$12.5M
2 -$10.1M
3 -$6.07M
4
Goldman Sachs
Goldman Sachs
New York
-$4.63M
5
State Street
State Street
Massachusetts
-$4.36M